| 000 | 01355 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250511200359.0 | ||
| 264 | 0 | _c19910717 | |
| 008 | 199107s 0 0 eng d | ||
| 022 | _a1040-8746 | ||
| 024 | 7 |
_a10.1097/00001622-199102000-00004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRoss, D D | |
| 245 | 0 | 0 |
_aCellular and pharmacologic aspects of drug resistance in acute myeloid leukemia. _h[electronic resource] |
| 260 |
_bCurrent opinion in oncology _cFeb 1991 |
||
| 300 |
_a21-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B, Member 1 |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aBiological Transport |
| 650 | 0 | 4 |
_aCytarabine _xpharmacokinetics |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xanalysis |
| 650 | 0 | 4 |
_aDaunorubicin _xpharmacokinetics |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aGene Amplification |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xgenetics |
| 650 | 0 | 4 |
_aNeoplastic Stem Cells _xdrug effects |
| 650 | 0 | 4 | _aRetrospective Studies |
| 773 | 0 |
_tCurrent opinion in oncology _gvol. 3 _gno. 1 _gp. 21-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00001622-199102000-00004 _zAvailable from publisher's website |
| 999 |
_c1681539 _d1681539 |
||